肿瘤儿童疫苗接种状况、效果与安全性的研究进展
儿童恶性肿瘤是儿童第二位常见死因,治疗技术进步使长期生存率显著提高,但疾病本身和治疗均可损害免疫功能。本文综述国内外文献和共识,梳理肿瘤儿童治疗后疫苗接种状况、效果与安全性,指出该类免疫功能受损肿瘤康复者缺乏详细接种数据且尚无权威统一接种建议。
要点
- 儿童恶性肿瘤为儿童第二位常见死因,疾病与治疗均可损害免疫功能。
- 肿瘤儿童治疗后疫苗接种状况、效果与安全性缺乏详细数据。
- 目前尚无权威且统一的肿瘤儿童疫苗接种建议。
核心结论
- 对免疫功能受损的肿瘤康复者接种疫苗的情况、效果及安全性缺乏详细数据,尚无权威且统一的接种建议。
研究设计与样本
- 本文为综述,梳理和总结国内外部分学者有关肿瘤儿童预防接种的文献和共识。
主要发现
- 儿童恶性肿瘤为儿童第二位常见死因,治疗技术进步使肿瘤儿童长期生存率显著提高。
- 疾病本身和治疗均可损害儿童免疫功能,使患儿易患感染性疾病及继发严重并发症,甚至成为传染源。
- 对免疫功能受损的肿瘤康复者接种疫苗的情况、接种后效果及安全性缺乏详细数据。
临床怎么用
- 本文旨在为我国肿瘤儿童预防接种领域的工作与实践提供参考,原文未据此给出具体推荐。
局限性
- 原文指出对免疫功能受损的肿瘤康复者接种疫苗的情况、效果及安全性缺乏详细数据,尚无权威且统一的接种建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Malignant tumors in children are one of the most important diseases that threaten the health and quality of life of children and are the second most common cause of death in children.With the continuous improvement and progress of treatment technology, the long-term survival rate of children with tumor has been significantly improved, but both the disease itself and the treatment can impair the immune function of children, which makes them vulnerable to various infectious diseases and secondary serious complications, and even become a source of infection, endangering the health of others. Vaccination is the most cost-effective measure to prevent infectious diseases. For children with normal immune functions, the benefits of vaccination usually outweigh the disadvantages. However, there is a lack of detailed data on the vaccination situation, efficacy and safety of vaccine use for such immunocompromised tumor survivors, and there are no authoritative and uniform vaccination recommendations. This article reviewed and summarized the literature and consensus of some domestic and foreign scholars on current status of post-treatment vaccination status, efficacy and safety of vaccination for children with tumors after treatment, with the aim of providing a reference for the practice in this field in China. 儿童恶性肿瘤是威胁儿童生命健康和影响儿童生命质量的重要疾病之一,为儿童第二位常见死因。随着治疗技术的不断完善与进步,肿瘤儿童的长期生存率得到显著提高,但疾病本身和治疗均可损害儿童免疫功能,导致患儿容易罹患各种感染性疾病以及继发严重并发症,甚至成为传染源,危害他人健康。疫苗接种是预防传染病最经济有效的措施。对于拥有正常免疫功能的儿童而言,疫苗接种通常利大于弊。但对这类免疫功能受损的肿瘤康复者接种疫苗的情况、接种后的效果及安全性等方面均缺乏详细数据,尚无权威且统一的接种建议。本文对国内外部分学者有关肿瘤儿童预防接种的文献和共识进行梳理和总结,旨在为我国该领域的工作与实践提供参考。.
引用
- Xu YY, Chen QH, Liu Y, et al. [Research progress of vaccination status, efficacy and safety in children with tumor]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024. PMID: 38228554. doi:10.3760/cma.j.cn112150-20230213-00101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。